Fracture Risk Evaluation of Bone Metastases Derived From Carcinoma

Launched by COSTANTINO ERRANI · Jul 23, 2024

Keywords

ClinConnect Summary

This clinical trial is studying the risk of fractures in patients who have bone metastases, which means cancer that has spread to the bones from other parts of the body. Researchers will review the medical records and imaging results of around 750 patients who were treated for bone metastases between January 2010 and December 2022. The goal is to better understand how these bone metastases affect fracture risk, which can help doctors provide better care for patients in the future.

To be eligible for this study, participants need to be at least 18 years old and have a diagnosis of bone metastases from any type of cancer. It’s important that researchers have access to imaging and clinical data, as well as at least one follow-up appointment within the year after diagnosis. If you or a family member meet these criteria, you may be able to participate. Those involved can expect to have their medical information reviewed to contribute to a larger understanding of how bone metastases impact fracture risk, which could lead to improved treatment and prevention strategies for future patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age ≥ 18 years
• • Diagnosis of bone metastasis from carcinoma, regardless of the type of carcinoma, and of the number and location of the metastases
• • Availability of imaging and clinical data
• • Availability of at least one follow-up during the last 12 months form diagnosis
• Exclusion Criteria:
• • At least one inclusion creteria not met